Premium
The burden of childhood cancer in Mexico: Implications for low‐ and middle‐income countries
Author(s) -
RiveraLuna Roberto,
ZapataTarres Marta,
ShalkowKlincovstein Jaime,
VelascoHidalgo Liliana,
OlayaVargas Alberto,
FinkelsteinMizrahi Nicole,
CárdenasCardós Rocío,
AguilarOrtiz Marco R.
Publication year - 2017
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.26366
Subject(s) - medicine , childhood cancer , abandonment (legal) , accreditation , pediatric cancer , economic shortage , government (linguistics) , low and middle income countries , family medicine , incidence (geometry) , cancer , pediatric oncology , cancer incidence , developing country , economic growth , medical education , linguistics , philosophy , physics , optics , political science , law , economics
In Mexico, childhood cancer incidence and mortality have increased in the last decade. Through government actions since 2005, the Popular Medical Insurance (PMI) program for childhood cancer was created. The objective of PMI was to offer early cancer diagnosis, standardized treatment regimens, and numerous pediatric oncology residency programs. It has also accredited 55 national hospitals for the care of these children. Current problems still present under the PMI include shortage of pediatric oncologists and nurses and high rate of abandonment of treatment. Our aim is to describe the current scenario of childhood cancer care in Mexico, especially from the perspective of the PMI and how it has impacted human resources, infrastructure, and medical education.